Sable Bio

Sable Bio

Private
United KingdomAI, Data & Cloud Infrastructurehttps://www.sablebio.com

Last Round

Seed

Feb 11, 2026

Total Funding Raised

$5.64M

Momentum Score

25 /100

Company Overview

Sable Bio is a UK-based technology startup that has developed an AI-powered platform for drug safety assessment. The platform is designed to help biotech and pharmaceutical companies evaluate drug target safety and predict potential toxicity risks early in the development process. By integrating and analyzing multimodal data from clinical, genetic, experimental, and literature sources, the company aims to reduce the time and cost associated with drug discovery and minimize clinical trial failures. The company was founded in 2023 by experts from the AI drug discovery field and secured pre-seed funding in February 2024.

Sector

AI, Data & Cloud Infrastructure

Verticals

Drug Discovery, Medical AI, Biotechnology, Clinical Trials, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

predictive toxicologydrug safety predictionAI drug discoveryin silico toxicologytarget intelligencedrug safety platformtoxicology risk assessmenttarget safety assessmentpharma AILLMsearly drug developmentcausal inferencebiomedical data analysisB2B SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sable Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sable Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 11, 2026
Pre SeedFeb 6, 2024

Key People

Founding team and executive leadership

Olly Oechsle

CTO

Executive Team

Sable Bio Investors

Notable investors and investment history

InvestorRounds
MMC VenturesSeed
Episode 1 VenturesSeed, Pre Seed
SeedcampSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2026

    $4M raised in Seed round.

Sable Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sable Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sable Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited Kingdom
Employee Range14
Year Founded2023
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.